Drugs / MK6592
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00359671 | Dec 2006 → Jul 2007 | cancer | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK6592 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00359671 ↗ |
| Known as | VX-667 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545378 ↗ |
| Modality | Small molecule | — CHEMBL3545378 ↗ |